Barbituric Acid

Barbituric Acid

SCHEMBL5924412

I.O=C1CC(=O)NC(=O)N1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Barbituric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.52
CYP1A2 P05177 1/20 0.52
HPGD P15428 1/20 0.52
HIF1A Q16665 1/20 0.52
HSD17B10 Q99714 1/20 0.52
CRBN Q96SW2 5/20 0.41
KDM4E B2RXH2 1/20 0.37
OGT O15294 1/20 0.37
USP2 O75604 1/20 0.37
MAPT P10636 1/20 0.37
RECQL P46063 1/20 0.37
BLM P54132 1/20 0.37
ITGB3 P05106 1/20 0.36
ITGB1 P05556 1/20 0.36
ITGAV P06756 1/20 0.36
ITGA4 P13612 1/20 0.36
AHR P35869 5/20 0.35
PDK2 Q15119 1/20 0.35
TDP2 O95551 1/20 0.32
CASP3 P42574 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Barbituric Acid SCHEMBL38707 0.96
Barbituric Acid SCHEMBL4560317 0.96 ALDH1A1 (0.55) ALDH1A1CYP1A2HPGDHIF1AHSD17B10
Barbituric Acid SCHEMBL9941322 0.96
Barbituric Acid SCHEMBL1974368 0.93 ALDH1A1 (0.52) ALDH1A1CYP1A2HPGDHIF1AHSD17B10
Barbituric Acid SCHEMBL1973453 0.93 ALDH1A1 (0.52) ALDH1A1CYP1A2HPGDHIF1AHSD17B10
Barbituric Acid SCHEMBL4278190 0.93 ALDH1A1 (0.52) ALDH1A1CYP1A2HPGDHIF1AHSD17B10
Barbituric Acid SCHEMBL11379882 0.93 ALDH1A1 (0.52) ALDH1A1CYP1A2HPGDHIF1AHSD17B10
Barbituric Acid SCHEMBL1973830 0.93 ALDH1A1 (0.52) ALDH1A1CYP1A2HPGDHIF1AHSD17B10
Barbituric Acid SCHEMBL1972516 0.93 ALDH1A1 (0.52) ALDH1A1CYP1A2HPGDHIF1AHSD17B10
Barbituric Acid SCHEMBL4663533 0.90 ALDH1A1 (0.50) ALDH1A1CYP1A2HPGDHIF1AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060120956-A1 Imaging agents comprising barbituric acid derivatives KOPKA KLAUS 2006-06-08 US disclosed
EP-1549317-A1 IMPROVED IMAGING AGENTS COMPRISING BARBITURIC ACID DERIVATIVES GE Healthcare Limited (GB) 2005-07-06 EP disclosed
WO-2004032936-A1 IMPROVED IMAGING AGENTS COMPRISING BARBITURIC ACID DERIVATIVES AMERSHAM PLC (GB) 2004-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060120956-A1 Imaging agents comprising barbituric acid derivatives CA5A, GABRA5, CA5B ALDH1A1 1222/4885CYP1A2 2230/4885HPGD 948/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.